The FDA and CDC, in collaboration with state and local partners, are investigating illnesses in a multistate outbreak of Salmonella Typhimurium infections linked to MOGO-brand moringa powder capsules distributed by MOGO Moringa LLC of St. Louis, MO. This is a new outbreak, and this investigation is separate from previous outbreaks of Salmonella Newport & Kentucky and Salmonella Typhimurium & Newport, both linked to moringa powder. Based on epidemiological information collected by the CDC, a total of 18 people infected with the outbreak strain of Salmonella have been reported from 14 states (CA, FL, GA, IL, MA, MI, MN, NC, ND, OR, PA, SC, TN, and WA). Illnesses started on dates ranging from February 3, 2026, to April 7, 2026. Of the seven people interviewed, five (71%) reported taking moringa powder capsules, including four who reported taking MOGO-brand capsules. There have been 7 hospitalizations, with no deaths reported. On May 25, 2026, MOGO Moringa LLC recalled lot #15525AA EXP 6/2027 and lot #00926AA EXP 1/2028 of MOGO-brand Pure Moringa Oleifera capsules. Consumers and retailers who purchased recalled MOGO-brand moringa powder capsules should not eat, sell, or further distribute these capsules and should throw them away. The FDA is conducting a traceback investigation to determine the source of contamination and is working with state partners to collect samples. The FDA will update this advisory with new information as it becomes available. FDA’s investigation is ongoing. @ https://www.fda.gov/food/outbreaks-foodborne-illness/outbreak-investigation-salmonella-moringa-leaf-powder-may-2026?utm_medium=email&utm_source=govdelivery
